TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13AAnna‐Leigh Brown, Mary Poss, Pietro Fratta et al.|Nature|2022Cited by 510
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated GliaOliver H. Tam, Molly Hammell, Robert W. Baloh et al.|Cell Reports|2019Cited by 333
Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanismErin G. Conlon, James L. Manley, Delphine Fagegaltier et al.|eLife|2018Cited by 87
Cell environment shapes TDP-43 function with implications in neuronal and muscle diseaseUrša Šušnjar, Towfique Raj, Neva Škrabar et al.|Communications Biology|2022Cited by 52
Combination therapy with sirolimus (rapamycin) and tacrolimus (FK-506) in treatment of refractory minimal change nephropathy, a clinical case reportPreeti Patel, Áine Burns, Suvankar Pal et al.|Nephrology Dialysis Transplantation|2005Cited by 14